St Jude Medical Inc. (STJ)
STJ (NYSE:Health Services)
$45.32
-0.55
-1.20%
Today's Range: 45.24 - 46.18 |
STJ Avg Daily Volume: 2,325,900
| Last Update: 06/19/13 - 4:00 PM EDT |
| Volume: 1,759,717 |
| YTD Performance: 25.40%
|
| Open: $45.81 |
| Previous Close: $45.87 |
| 52 Week Range: $30.25 -
$47.45 |
| Oustanding Shares: 283,362,731 |
| Market Cap: 12,997,848,471 |
6-Month Chart
TheStreet Ratings Grade for STJ
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
13 |
12 |
11 |
12 |
| Moderate Buy |
0 |
0 |
0 |
0 |
| Hold |
10 |
12 |
12 |
13 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
2 |
0 |
0 |
0 |
| Mean Rec. |
2.12 |
2.00 |
2.04 |
2.04 |
| Latest Dividend: |
0.25 |
| Latest Dividend Yield: |
2.18% |
| Dividend Ex-Date: |
06/26/13 |
| Price Earnings Ratio: |
18.27 |
|
| Price Earnings Comparisons: |
| STJ |
Sector Avg. |
S&P 500 |
| 18.27 |
18.30 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
8.58%
|
21.18%
|
21.21%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
-1.90 |
0.18 |
0.05 |
| Net Income |
-8.90 |
-0.03 |
-0.01 |
| EPS |
-5.20 |
0.05 |
0.02 |
| Earnings for STJ: |
| EBITDA |
1.67B |
| Revenue |
5.50B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.94 |
$0.88 |
$3.69 |
$3.93 |
| Number of Analysts |
18 |
18 |
19 |
19 |
| High Estimate |
$0.95 |
$0.90 |
$3.73 |
$4.08 |
| Low Estimate |
$0.92 |
$0.84 |
$3.60 |
$3.75 |
| Prior Year |
$0.88 |
$0.83 |
$3.48 |
$3.69 |
| Growth Rate (Year over Year) |
6.63% |
5.89% |
6.17% |
6.42% |
May 28, 2013 | 7:55 AM EDT
STJ was downgraded from Hold to Sell, Canaccord Genuity said. $35 price target. Earnings quality is declining and the company is facing...
| May 19, 2013 | 5:00 PM EDT
This medical-device maker is one of my favorite stocks for the year ahead.
May 14, 2013 | 7:10 AM EDT
Bank of America Merrill Lynch Health Care Conference (Day 1 of 3) - 05/14/13 - 05/16/13 Las Vegas, NV
| Mar 06, 2013 | 3:48 PM EST
How much to buy?
Feb 05, 2013 | 11:32 AM EST
Feb 04, 2013 | 7:45 AM EST
STJ was upgraded from Neutral to Outperform, Credit Suisse said. $48 price target. Left investor meeting with a more favorable outlook ...
Feb 01, 2013 | 6:43 AM EST
St. Jude Medical, Inc. 2013 Investor Meeting - 8AM New York
| Jan 29, 2013 | 9:00 AM EST
Now we get to the trades themselves.
Jan 15, 2013 | 8:05 AM EST
Shares of STJ now seen reaching $39, Jefferies said. Estimates also raised on ending of near- term pressure from Riata/Durata. Hold rat...
Jan 10, 2013 | 8:22 AM EST
STJ was downgraded to Market Perform, BMO Capital said. $40 price target. Company lacks near-term catalysts.
